# The Cardiovascular and Renal Effects of Moringa Oleifera Extracts and Stevia Rebaudiana Bertoni in Patients With Type II Diabetes Mellitus

> **NCT04254029** · PHASE4 · COMPLETED · sponsor: **Yaounde Central Hospital** · enrollment: 19 (estimated)

## Conditions studied

- Benefits of a Capsules of Moringa Oleifera and Stevia Rebaudiana Bertoni in Patients With Type 2 Diabetes Mellitus Before and After 45 Days of add-on Therapy

## Interventions

- **DIETARY_SUPPLEMENT:** MOROLSTEVER1

## Key facts

- **NCT ID:** NCT04254029
- **Lead sponsor:** Yaounde Central Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-01
- **Primary completion:** 2017-05-01
- **Final completion:** 2017-05-01
- **Target enrollment:** 19 (ESTIMATED)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04254029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04254029, "The Cardiovascular and Renal Effects of Moringa Oleifera Extracts and Stevia Rebaudiana Bertoni in Patients With Type II Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04254029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*